Illumina Inc (ILMN)
136.99
+5.31
(+4.03%)
USD |
NASDAQ |
Nov 21, 16:00
136.22
-0.77
(-0.56%)
After-Hours: 04:15
Illumina Revenue (Quarterly): 1.08B for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 1.08B |
June 30, 2024 | 1.112B |
March 31, 2024 | 1.076B |
December 31, 2023 | 1.122B |
September 30, 2023 | 1.119B |
June 30, 2023 | 1.176B |
March 31, 2023 | 1.087B |
December 31, 2022 | 1.083B |
September 30, 2022 | 1.115B |
June 30, 2022 | 1.162B |
March 31, 2022 | 1.223B |
December 31, 2021 | 1.199B |
September 30, 2021 | 1.108B |
June 30, 2021 | 1.126B |
March 31, 2021 | 1.093B |
December 31, 2020 | 953.00M |
September 30, 2020 | 794.00M |
June 30, 2020 | 633.00M |
March 31, 2020 | 859.00M |
December 31, 2019 | 952.00M |
September 30, 2019 | 907.00M |
June 30, 2019 | 838.00M |
March 31, 2019 | 846.00M |
December 31, 2018 | 867.00M |
September 30, 2018 | 853.00M |
Date | Value |
---|---|
June 30, 2018 | 830.00M |
March 31, 2018 | 782.00M |
December 31, 2017 | 777.00M |
September 30, 2017 | 714.00M |
June 30, 2017 | 662.00M |
March 31, 2017 | 598.00M |
December 31, 2016 | 619.00M |
September 30, 2016 | 607.00M |
June 30, 2016 | 600.00M |
March 31, 2016 | 572.00M |
December 31, 2015 | 591.79M |
September 30, 2015 | 550.27M |
June 30, 2015 | 539.38M |
March 31, 2015 | 538.56M |
December 31, 2014 | 512.38M |
September 30, 2014 | 480.63M |
June 30, 2014 | 447.57M |
March 31, 2014 | 420.78M |
December 31, 2013 | 387.33M |
September 30, 2013 | 356.80M |
June 30, 2013 | 346.09M |
March 31, 2013 | 330.96M |
December 31, 2012 | 309.26M |
September 30, 2012 | 285.87M |
June 30, 2012 | 280.61M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
633.00M
Minimum
Jun 2020
1.223B
Maximum
Mar 2022
1.054B
Average
1.100B
Median
Revenue (Quarterly) Benchmarks
Exact Sciences Corp | 708.66M |
Delcath Systems Inc | 11.20M |
Star Equity Holdings Inc | 13.66M |
CytoSorbents Corp | 8.613M |
Progyny Inc | 286.62M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | 705.00M |
Total Expenses (Quarterly) | 827.00M |
EPS Diluted (Quarterly) | 4.42 |
Enterprise Value | 22.78B |
Gross Profit Margin (Quarterly) | 68.98% |
Profit Margin (Quarterly) | 65.28% |
Earnings Yield | -7.27% |
Operating Earnings Yield | 1.10% |
Normalized Earnings Yield | -2.457 |